NUMERO: #20250337

Título: THE LEGAL PATHWAYSAND CASE LAWON PHOTOBIOMODULATION THERAPYFOR ORAL MUCOSITISIN CANCER CARE: ARETROSPECTIVECROSS-SECTION

Nome do Apresentador: Danielle Martins STARTARI

Categoria do Trabalho: Painel de pesquisa científica (PPC)

Área Temática: Oncologia

Resumo: Objectives: To identify the legal pathways to patient access to photobiomodulation therapy (PBMT) for oral mucositis (OM) management in Brazilian cancer care. Study design: This retrospective cross-sectional study assessed electronic databases of the Courts of Justice from all Brazilian states, the Superior Court of Justice and the Federal Supreme Court, yielding 180 court rulings for mucositis. Results: A total of 50 court rulings, adjudicated between 2005 and 2024, met the eligibility criteria. The rulings were fully granted in 41 cases (82%) and partially granted in 9 cases (18%). Partially granted rulings typically involved the denial of compensation for moral damages. In 47 cases (94%), the rulings were directed to health insurance providers, while 3 cases (6%) involved public healthcare (SUS). The mean time elapsed between the filing date and the interim relief decision was 13.3 days (SD = 28.3; range: 1-115 days). Chemotherapy was the most common cancer treatment modality, followed by radiotherapy and cHSCT (candidates for hematopoietic stem cells transplantation). Conclusions: This pioneer study in the field of health law demonstrated a consistent legal framework supporting access to PBMT for the management of OM in cancer patients across various regions of Brazil.

Autor 1:  Danielle Martins STARTARI

E-mail 1:  [email protected]

Autor 2:   Thaí

E-mail 2:  s Cristina Esteves-Pereira

Autor 3 :  Erik Navarro Wolkart

E-mail 3:  [email protected]

Autor 4:  Marcela Pires

E-mail 4:  [email protected]

Autor 5:  Marcio Ajudarte Lopes

E-mail 5:  [email protected]

Autor 6:  Alan Roger Santos Silva

E-mail 6:  [email protected]